NEW YORK (GenomeWeb News) – BellBrook Labs today announced a revised distribution agreement with Cambio to include BellBrook's full Transcreener product line of HTS assays.
Under the terms of the revised deal, Cambio becomes the exclusive distributor of BellBrook's Transcreener HTS assays in the UK. Cambio will also distribute BellBrook's new Transzyme product line of turnkey methyltransferase assay kits combining precalibrated purified methytransferase enzymes and substrates from Reaction Biology with BellBrook's Transcreener Epigen Methyltransferase detection reagents.
BellBrook said the deal is its first granting exclusive distribution rights to a territory in Europe. Further financial and other terms were not disclosed.
The Transcreener HTS assays cover thousands of enzymes, including kinases, as well as emerging target families, such as methyltransferases, GTPases, and glycosyltransferases, BellBrook said, adding that the Transcreener assays are the only technology for direct detection of nucleotide enzyme products.
In March 2012, Cambio was named UK distributor for BellBrook's Transcreener HTS assays and iuvo Microconduit Array Platform.